Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: Mechanisms of action

Endocrinology

Volumn 137, Issue 12, 1996, Pages 5364-5369

  Kovács, Magdolna ^a,b,d   Zarándi, Márta ^a,b   Halmos, Gábor ^a,b   Groot, Kate ^a   Schally, Andrew V ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA Medical Center   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR[1-29]; HORMONE ANTAGONIST; HORMONE RECEPTOR; MZ 4 71; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; BODY WEIGHT; BOLUS INJECTION; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONE ACTION; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030472413     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.12.8940358     Document Type: Article

References (40)

1. Clark RG, Robinson ICAF 1985 Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF- deficient rats. Nature 314:281-283
2. Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM 1985 Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 312:4-9
3. Gelato MC, Ross JL, Malozowsky S, Pescovitz OH, Skerda M, Cassoria F, Loriaux DL, Merriam GR 1985 Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. J Clin Endocrinol Metab 61:444-450
4. 2 on the GH release in rat. Neuroendocrinology 59:371-379
5. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, Rahal JO 1995 Growth hormone-releasing hormone. Synthesis and signaling. In: Bardin CW (ed) Recent Progress in Hormone Research, Academic Press, San Diego, California, vol. 50:35-73
6. Kovács M, Fáncsik A, Hrabovsky E, Mezó I, Teplán I, Flerkó B 1995 Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30)-NH2 on the GH release in rats treated with monosodium glutamate. J Neuroendocrinol 7:703-712
7. Wehrenberg WB, Bloch B, Phillips BJ 1984 Antibodies to growth hormone-releasing factor inhibit somatic growth. Endocrinology 115:1218-1220
8. Wehrenberg WB 1986 The role of growth hormone-releasing factor and somatostatin on somatic growth in rats. Endocrinology 118:489-494
9. Gruaz NM, Arsenijevic Y, Wehrenberg WB, Sizonenko PC, Aubert ML 1994 Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor does not disturb the course of sexual maturation and fertility in the female rat. Endocrinology 135:509-519
10. Coy D, Murphay WA, Sueiras-Diaz J, Coy EJ, Lance VA 1985 Structure-activity studies on the N-terminal region of growth hormone releasing factor. J Med Chem 28:181-185
11. Lumpkin MD, Mulroney SE, Haramati A 1989 Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist. Endocrinology 124:1154-1159
12. Lumpkin MD, McDonald JK 1989 Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the concious rat with a peptidic GRF antagonist. Endocrinology 124:1522-1531
13. Wheeler MD, Wehrenberg WW, Stune DM 1991 Growth hormone regulation by growth hormone-releasing hormone in infant rhesus monkeys. Biol Neonate 60:19-28
14. Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K 1996 Plasma GH responses to human GHRH-antagonist in normal subjects. Eur J Endocrinol 134:67-72
15. Jaffe CA, DeMott Frieberg R, Barkan AL 1993 Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. J Clin Invest 92:695-701
16. Zarándi M, Horváth JE, Halmos G, Pinski J, Nagy A, Groot K, Rékási Z, Schally AV 1994 Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci 91:12298-12302
17. Daughaday WH 1990 Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1-4
18. Macaulay VM 1992 Insulin-like growth factors and cancer. Brit J Cancer 65:311-320
19. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M 1995 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55:2007-2011
20. Angelloz-Nicoud P, Binoux M 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492
21. Schally AV 1988 Oncological applications of somatostatin analogs. Cancer Res 48:6977-6985
22. Pinski J, Schally AV, Groot K, Halmos G, Szepesházi K, Zarándi M, Armatis P 1995 Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst 87:1787-1794
23. Horváth JE, Zarándi M, Groot K, Schally AV 1995 Effect of long-acting antagonists of growth hormone-releasing hormone on GH and cyclic AMP release in superfused rat pituitary cells. Endocrinology 136:3849-3855
24. Kovács M, Mezó I, Teplán I, Hollósi M, Kajtár J, Flerkó B 1993 New Gaba-containing analogues of hGH-RH(1-30)-amide. Detailed in vivo biological examinations. J Endocrinol Invest 16:799-805
25. Vígh S, Schally AV 1984 Interactions between hypothalamic peptides in a superfused pituitary cell system. Peptides [Suppl 1] 5:241-247
26. Csernus V, Schally AV 1991 The dispersed cell superfusion system. In: Greenstein B (ed) Neuroendocrine Research Methods. Harwood Academic Publishers, London, pp 66-102
27. Rekasi Z, Schally AV 1993 A method for evaluation of activity of antagonistic analogs of growth hormone-releasing hormone in a superfusion system. Proc Natl Acad Sci USA 90:2146-2149
28. Breier BH, Gallaher BW, Gluckman PD 1991 Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls. J Neuroendocrinol 128:347-357
29. Daughaday WH, Mariz IK, Blethen SL 1980 Inhibition of access of bound somatomedin to membrane receptor and immunoglobulin sites: a comparison of radio-receptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 51:781-788
30. Halmos G, Rékási Z, Szóke B, Schally AV 1993 Use of radioreceptor assay and cell superfusion system for in vitro screening of analogs of growth hormone-releasing hormone. Receptor 3:87-97
31. Munson PJ, Rodbard D 1980 A versatile computerised approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
32. McPherson GA 1985 Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-228
33. Plotsky PM, Vale W 1985 Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophyseal-portal circulation of the rat. Science 230:461-463
34. Horikawa R, Hellmann P, Cella SG, Torsello A, Day RN, Muller EE, Thorner MO 1996 Growth hormone-releasing factor (GRF) regulates expression of its own receptor. Endocrinology 137:2642-2645
35. 2 induces compensatory linear growth in GH-deficient rats: mechanisms of action. Neuroendocrinology, 64:169-176
36. Millard WJ, Martin Jr JB, Audet J, Sager SM, Martin JB 1982 Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110:540-550
37. Lin CL, Lin S-C, Chang C-P, Rosenfeld MG 1992 Pit-1 dependent expression of the receptor for growth hormone-releasing factor mediates pituitary cell growth. Nature 360:765-768
38. Maiter D, Underwood LE, Marti JB, Koenig JI 1991 Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 128:1100-1106
39. Zapf J, Hauri C, Waldvogel M, Froesch ER 1986 Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomised rats. J Clin Invest 77:1768-1775
40. Nieves-Rivera F, Kerrigan JR, Krieg RJ, Egan J, Hwang LJ, Truumees E, Veldhuis JD, Evans WS, Rogol AD 1993 Altered growth hormone (GH) secretion in vivo and in vitro in the diabetes-prone BB/Worcester rat. Growth Regul 3:235-244